Biostax Corp.
CIK 0001559356
Revenue (TTM)
$113.5K
Q2 Aug 2024
Net Income (TTM)
−$1.67M
+33.2% YoY
Q2 Aug 2024
EPS Diluted (TTM)
−$0.02
+70.0% YoY
Q2 Aug 2024
Gross Margin
58.0%
Q2 Aug 2024
Operating Margin
-1,194.0%
Q2 Aug 2024
Net Margin
-1,474.5%
Q2 Aug 2024
Free Cash Flow (TTM)
−$356.09K
Q2 Aug 2024
Cash
$5.45K
Q2 Aug 2024
Total Debt
—
Q2 Aug 2024
Shares Outstanding
83.74M sh
Q2 Aug 2024
Revenue & Net Income
EPS (Diluted)
Margins
Cash Flow
Revenue Growth (YoY)
No data available for this metric.